SEQC Spanish Society of Laboratory Medicine

Spanish Society of Laboratory Medicine

'Advances in Laboratory Medicine', the new journal of the SEQCML

Dr. Álvaro González Hernández, Editor-in-Chief of the Adv Med Lab journal, explains this project

Research is made known to the rest of the scientific community through the publication of articles in journals seeking to reach as many readers as possible. Recently, the Spanish Society of Laboratory Medicine (SEQCML) launched a new journal, called Avances en Medicina de Laboratorio -Advances in Laboratory Medicine (Adv Med Lab) to facilitate the dissemination of scientific works related to Laboratory Medicine, especially with regard to the development and interpretation of analytical tests. The founding of the journal was inspired by previous journals published by the SEQCML, some in conjunction with other scientific societies. The editors of these previous journals deserve special recognition for their selfless dedication to their development. Based on previous experience, Adv Med Lab was born with a renewed spirit to be a journal of international prestige at the service of the scientific community.

Within the interest of promoting the dissemination of research, Adv Med Lab has chosen a different approach with respect to other journals, such as Open Access and being Spanish-English bilingual. At the same time, articles will be accepted based on peer review and with special attention to ethical aspects. In addition, Adv Med Lab was founded with the aspiration of being indexed in the main databases, especially those that use bibliometric indexes to evaluate the scientific quality of papers and journals. An example of these is the well-known Journal Citation Reports, which evaluates the world's leading journals using the “Impact Factor” indicator. Obtaining this indexing is a difficult task that requires time and work, but is necessary to achieving maximum recognition and visibility.

Access to the information in a scientific journal traditionally involves a subscription cost, in both paper and electronic formats. Consequently, it is a limitation for many researchers and professionals to know of these published papers if they do not have the corresponding subscription. Faced with this, the Open Access movement has emerged, which promotes the free availability of scientific literature through the Internet, so that any user has free access to the article and, consequently, the author achieves greater dissemination of their research. Based on the philosophy of achieving maximum dissemination of its content, Adv Lab Med has chosen to be an electronic journal, bypassing the paper format, and Open Access. There are several Open Access models, but initially the most extensive one has been chosen, in which the entire cost of the publication process is assumed by the SEQCML, being free for both the reader and the author. This is an important difference from other Open Access journals, in which the author assumes the publication price, which usually ranges from around € 500-3,000.

It is well known that the universal language of science is English. However, the difficulty of writing science in English sometimes limits Spanish speakers when publishing their work in international journals. Therefore, Adv Lab Med has decided on a Spanish-English bilingual edition, translating the articles into the other language once accepted. In this way, it intends to prevent a good project from not reaching the dissemination it deserves for linguistic reasons. At the same time, keeping both versions allows it to reach a wider audience. With this commitment to a bilingual journal, it follows the example of other prestigious Spanish journals such as Emergencies, or the Spanish Journal of Cardiology. It is obvious that this involves an additional effort for the magazine, but we believe that it is amply compensated by the service provided to Spanish-speaking authors.

Peer review is essential to maintaining the quality of a scientific journal. The reviewers deserve special thanks, since they dedicate unrecognized and unpaid time to the evaluation of the work. As it cannot be otherwise, the acceptance of works by Adv Lab Med is based on this process, in which each submission is evaluated by several reviewers. These, as experts, examine the manuscript submitted for publication independently and critically. Being a reviewer means recognition as a specialist in that area of ​​knowledge and implies a responsibility to evaluate the merit of the work submitted by making constructive comments within a reasonable timeframe. On the other hand, the reviewer must be aware of the possibility of conflicts of interest and must reject the review of those manuscripts in which such conflict may arise, communicating this to the editor.

Adv Lab Med journal will be attentive to the various ethical aspects that may affect the quality of the published results. Within the commitment to offer readers novel and original information, plagiarism and works whose relevant results have been previously published will be monitored. It will be especially important that manuscripts containing results obtained from people clearly indicate that the work has been approved by the corresponding Ethics Committee and that the subjects of the study have signed the corresponding informed consent, if necessary. Any conflict of interest that is relevant to the published research should also be indicated. An example of a conflict of interest would be the financing of a trip or congress by the industry involved in the work.

In short, Adv Med Lab was born with the intention of being an important journal from a scientific point of view. The new journal was introduced in May in Barcelona at the EuroMedLab 2019 congress where it was well received. We hope that this project, which is being developed with great enthusiasm and hard work, will please everyone and serve as a channel for scientific dissemination of research in the Clinical Laboratory field.

For more information about the new journal, consult the following link by De Gruyter: https://www.degruyter.com/view/j/almed